Johnson, Kirk W.

Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo

Ring, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 532

Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward

Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R. (2007) · The Scientific World JOURNAL

Pain Mechanisms and TreatmentsNeuropeptides and Animal Physiology

Cited by 359

Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats

Cline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 228

Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle

Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Carter, L., Johnson, K., & Henry, R. R. (2002) · Diabetes

Metabolism, Diabetes, and CancerGlycogen Storage Diseases and Myoclonus

Cited by 198

Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes

Wagman, A., Johnson, K., & Bussiere, D. (2004) · Current Pharmaceutical Design

Wnt/β-catenin signaling in development and cancerDiabetes Treatment and Management

Cited by 153

Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence: Ibudilast and alcohol

Bell, R. L., Lopez, M. F., Cui, C., Egli, M., Johnson, K. W., Franklin, K. M., & Becker, H. C. (2015) · Addiction Biology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 138

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

Henriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism

Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 108

The glial cell modulator and phosphodiesterase inhibitor, AV411 (Ibudilast), attenuates prime- and stress-induced methamphetamine relapse

Beardsley, P. M., Shelton, K. L., Hendrick, E., & Johnson, K. W. (2010) · European Journal of Pharmacology

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 97